Gemcitabine and carboplatin in combination for the treatment of advanced, metastatic, non-small cell lung cancer

被引：9
|
作者：
Nagel, Sylke [3 ]
Califano, Raffaele [2 ]
Thatcher, Nicholas [1 ]
Blackhall, Fiona [1 ]
机构：
[1] Christie Hosp, Dept Med Oncol, Manchester M20 4BX, Lancs, England
[2] Osped Santa Maria Misericordia, SC Oncol Med, I-06120 Perugia, Italy
[3] Martha Maria Hosp, D-06120 Halle, Germany
来源：
EXPERT OPINION ON PHARMACOTHERAPY | 2007年 / 8卷 / 18期
关键词：
carboplatin; chemotherapy; gemcitabine; non-small-cell lung cancer;
D O I：
10.1517/14656566.8.18.3265
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The universally accepted first-line treatment for advanced (stage IIIB effusion/IV) non-small-cell lung cancer in patients with a good performance status is a platinum drug in combination with one of gemcitabine, paclitaxel, vinorelbine or docetaxel. Although cisplatin is generally the favoured platinum agent, gemcitabine partnered with carboplatin is convenient to administer and has a favourable toxicity profile. Here, the pharmacology, preclinical and clinical data to support the use of this regimen for the treatment of advanced non-small-cell lung cancer is evaluated.
引用
收藏
页码：3265 / 3275
页数：11
相关论文
共 50 条
  • [21] Vinorelbine, carboplatin and gemcitabine (VGC) in the treatment of untreated advanced/metastatic non-small cell lung cancer (NSCLC): A phase I study
    Piantedosi, FV
    Pontillo, V
    Brancaccio, L
    Crispino, C
    Biscione, GL
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S255 - S255
  • [22] Combination of Gemcitabine (Gem) and Carboplatin (Carbo) as first line treatment in non-small cell lung cancer (NSCLC)
    Carrato, A
    Alberola, V
    Massuti, B
    Galan, A
    Sanchez, JJ
    Garcia-Gomez, J
    Diaz-Fernandez, N
    Meana, A
    Rodriguez-Lescure, A
    Gonzalvez, ML
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 89 - 90
  • [23] Gemcitabine (GEM) and carboplatin (CBDCA) combination as first line treatment in non-small cell lung cancer.
    Alberola, V
    Carralo, A
    Massuti, B
    Juan, O
    Sánchez, JJ
    Gómez, JG
    Fernández, ND
    Meana, A
    Rodríguez-Lescure, A
    González, ML
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S66 - S66
  • [24] Gemcitabine and carboplatin in patients with locally advanced or metastatic non-small cell lung cancer: a prospective phase II study
    Kortsik, C
    Albrecht, P
    Elmer, A
    [J]. LUNG CANCER, 2003, 40 (01) : 85 - 90
  • [25] A randomized comparison of carboplatin/vinorelbine versus carboplatin/gemcitabine in advanced non-small cell lung cancer (NSCLC).
    Helbekkmo, N.
    Sundtroem, S. H.
    Aaseboe, U.
    Brunsvig, P. F.
    Von Plessen, C. L.
    Bremnes, R. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 372S - 372S
  • [26] Activity of gemcitabine and carboplatin in advanced non-small cell lung cancer: a phase II trial
    Masotti, A
    Zannini, G
    Gentile, A
    Morandini, G
    [J]. LUNG CANCER, 2002, 36 (01) : 99 - 103
  • [27] A phase I trial of paclitaxel, carboplatin, and gemcitabine in advanced non-small cell lung cancer
    Kelly, K
    Prindiville, S
    Bunn, PA
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (01) : 74 - 74
  • [28] Past, present, and future of gemcitabine and carboplatin regimens in advanced non-small cell lung cancer
    Edelman, MJ
    [J]. LUNG CANCER, 2002, 38 : S37 - S43
  • [29] Carboplatin and vinorelbine in untreated locally advanced and metastatic non-small cell lung cancer
    Horvath, L
    Boyer, M
    Clarke, S
    Beale, P
    Beith, J
    Underhill, C
    Stockler, M
    Bishop, J
    [J]. LUNG CANCER, 2001, 32 (02) : 173 - 178
  • [30] Sunitinib in Combination with Erlotinib for the Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Thongprasert, Sumitra
    Govindan, Ramaswamy
    Krzakowski, Maciej
    Szczesna, Aleksandra
    Strausz, Janos
    Makhson, Anatoly
    Tye, Lesley
    Zhang, Ke
    Chao, Richard C.
    Scagliotti, Giorgio V.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S375 - S375
12345